Literature DB >> 16307269

Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.

Carsten Skarke1, Anja Kirchhof, Gerd Geisslinger, Jörn Lötsch.   

Abstract

OBJECTIVE: To develop a rapid and reliable screening method for identifying the relevant cytochrome P450 (CYP) 1A2 alleles CYP1A2*1D (-2467Tdel), *1F (-163A>C), and *1K (-739T>G, -729C>T, -163A>C) that are in linkage disequilibrium with the functionally relevant CYP1A2 polymorphisms and therefore are considered to be predictive for the CYP1A2 phenotype.
METHODS: CYP1A2 single nucleotide polymorphisms (SNPs) -2467Tdel, -739T>G, -729C>T, and -163A>C were screened for in 495 healthy Caucasian volunteers using newly developed pyrosequencing duplex and simplex assays. Conventional sequencing of randomly selected samples served as quality control.
RESULTS: Frequencies were 7.9% for CYP1A2*1D, 31.8% for *1F, and 0.4% for *1K. The observed distribution of homozygous and heterozygous carriers of the alleles corresponded to the predicted one according to the Hardy-Weinberg law. It also corresponded to reported allelic frequencies from Caucasians but differed significantly from the distribution seen in other ethnicities. The most frequent haplotype was -2467T/-739T/-729C/-163A (allelic frequency 61.6%), followed by -2467T/-739T/-729C/-163C (30.5%), -2467Tdel/-739T/-729C/-163A (5.1%), -2467Tdel/-739G/-729C/-163A (1.2%), and -2467Tdel/-739T/-729C/-163C (1.1%). Complete linkage disequilibrium (value of D' nearly 1) existed between -2467Tdel, -739T>G, and -729C>T and between -729T>G and -163A>C.
CONCLUSIONS: Pyrosequencing facilitates rapid and reliable detection of those CYP1A2 alleles that, based on current knowledge, can be considered predictive for the CYP1A2 phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307269     DOI: 10.1007/s00228-005-0029-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  31 in total

1.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

2.  Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.

Authors:  Samar I Hamdy; Masahiro Hiratsuka; Kaori Narahara; Naomi Endo; Mervat El-Enany; Nadia Moursi; Mohammed S-E Ahmed; Michinao Mizugaki
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

3.  A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers.

Authors:  D Schrenk; D Brockmeier; K Mörike; K W Bock; M Eichelbaum
Journal:  Eur J Clin Pharmacol       Date:  1998-01       Impact factor: 2.953

4.  Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia.

Authors:  Kazutaka Shimoda; Toshiyuki Someya; Sachiyo Morita; Genta Hirokane; Aya Yokono; Saburo Takahashi; Masako Okawa
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-02       Impact factor: 5.067

5.  Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans.

Authors:  M Nakajima; T Yokoi; M Mizutani; M Kinoshita; M Funayama; T Kamataki
Journal:  J Biochem       Date:  1999-04       Impact factor: 3.387

6.  Frequency of -163 C>A and 63 C>G single nucleotide polymorphism of cytochrome P450 1A2 in two African populations.

Authors:  Collet Dandara; Patience T Basvi; Tashinga E Bapiro; Jane Sayi; Julia A Hasler
Journal:  Clin Chem Lab Med       Date:  2004       Impact factor: 3.694

Review 7.  Drug interactions and the cytochrome P450 system. The role of cytochrome P450 1A2.

Authors:  K Brøsen
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

8.  Association of caffeine intake and CYP1A2 genotype with ovarian cancer.

Authors:  Marc T Goodman; Ko-Hui Tung; Katharine McDuffie; Lynne R Wilkens; Timothy A Donlon
Journal:  Nutr Cancer       Date:  2003       Impact factor: 2.900

9.  Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.

Authors:  Eleni Aklillu; Juan Antonio Carrillo; Eyasu Makonnen; Karin Hellman; Marià Pitarque; Leif Bertilsson; Magnus Ingelman-Sundberg
Journal:  Mol Pharmacol       Date:  2003-09       Impact factor: 4.436

10.  Determination of urinary metabolites of caffeine for the assessment of cytochrome P4501A2, xanthine oxidase, and N-acetyltransferase activity in humans.

Authors:  B B Rasmussen; K Brøsen
Journal:  Ther Drug Monit       Date:  1996-06       Impact factor: 3.681

View more
  8 in total

Review 1.  Pharmacogenetics in psychiatry: are we ready for widespread clinical use?

Authors:  Maria J Arranz; Shitij Kapur
Journal:  Schizophr Bull       Date:  2008-08-27       Impact factor: 9.306

2.  Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians.

Authors:  Fabiana B Kohlrausch; Ángel Carracedo; Mara H Hutz
Journal:  Mol Biol Rep       Date:  2014-01-18       Impact factor: 2.316

3.  Frequencies of genetic polymorphisms related to triptans metabolism in chronic migraine.

Authors:  Giovanna Gentile; Serena Missori; Marina Borro; Alisa Sebastianelli; Maurizio Simmaco; Paolo Martelletti
Journal:  J Headache Pain       Date:  2010-03-06       Impact factor: 7.277

Review 4.  Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.

Authors:  Shu-Feng Zhou; Li-Ping Yang; Zhi-Wei Zhou; Ya-He Liu; Eli Chan
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 5.  Treatment of the first episode of schizophrenia: an update on pharmacologic and psychological interventions.

Authors:  Benedicto Crespo-Facorro; Rocío Pérez-Iglesias; Cesar González-Blanch; Ignacio Mata
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

6.  Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations.

Authors:  Angela Roco; Luis Quiñones; José A G Agúndez; Elena García-Martín; Valentina Squicciarini; Carla Miranda; Joselyn Garay; Nancy Farfán; Iván Saavedra; Dante Cáceres; Carol Ibarra; Nelson Varela
Journal:  Front Genet       Date:  2012-11-02       Impact factor: 4.599

7.  Development of an AmpliSeqTM Panel for Next-Generation Sequencing of a Set of Genetic Predictors of Persisting Pain.

Authors:  Dario Kringel; Mari A Kaunisto; Catharina Lippmann; Eija Kalso; Jörn Lötsch
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

8.  CYP1A2 mRNA Expression Rather than Genetic Variants Indicate Hepatic CYP1A2 Activity.

Authors:  Ferenc Fekete; Katalin Mangó; Annamária Minus; Katalin Tóth; Katalin Monostory
Journal:  Pharmaceutics       Date:  2022-02-27       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.